Anemia Treatment Drugs Market - Global Outlook and Forecast 2023-2028

Report ID: 1566576 | Published Date: Dec 2025 | No. of Page: 61 | Base Year: 2024 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%)

Impact of U.S Tarrifs Analyzed 2025 

1 Introduction to Research & Analysis Reports
    1.1 Anemia Treatment Drugs Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Anemia Treatment Drugs Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Anemia Treatment Drugs Overall Market Size
    2.1 Global Anemia Treatment Drugs Market Size: 2021 VS 2028
    2.2 Global Anemia Treatment Drugs Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Anemia Treatment Drugs Players in Global Market
    3.2 Top Global Anemia Treatment Drugs Companies Ranked by Revenue
    3.3 Global Anemia Treatment Drugs Revenue by Companies
    3.4 Top 3 and Top 5 Anemia Treatment Drugs Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Anemia Treatment Drugs Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Anemia Treatment Drugs Players in Global Market
        3.6.1 List of Global Tier 1 Anemia Treatment Drugs Companies
        3.6.2 List of Global Tier 2 and Tier 3 Anemia Treatment Drugs Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Anemia Treatment Drugs Market Size Markets, 2021 & 2028
        4.1.2 Supplements
        4.1.3 Antibiotics
        4.1.4 Immunosuppressant
        4.1.5 Bone Marrow Stimulants
        4.1.6 Corticosteroids
        4.1.7 Gene Therapy
        4.1.8 Iron Chelating Agents
    4.2 By Type - Global Anemia Treatment Drugs Revenue & Forecasts
        4.2.1 By Type - Global Anemia Treatment Drugs Revenue, 2017-2022
        4.2.2 By Type - Global Anemia Treatment Drugs Revenue, 2023-2028
        4.2.3 By Type - Global Anemia Treatment Drugs Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Anemia Treatment Drugs Market Size, 2021 & 2028
        5.1.2 Iron deficiency anemia
        5.1.3 Thalassemia
        5.1.4 Aplastic anemia
        5.1.5 Hemolytic anemia
        5.1.6 Sickle cell anemia
        5.1.7 Pernicious anemia
    5.2 By Application - Global Anemia Treatment Drugs Revenue & Forecasts
        5.2.1 By Application - Global Anemia Treatment Drugs Revenue, 2017-2022
        5.2.2 By Application - Global Anemia Treatment Drugs Revenue, 2023-2028
        5.2.3 By Application - Global Anemia Treatment Drugs Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Anemia Treatment Drugs Market Size, 2021 & 2028
    6.2 By Region - Global Anemia Treatment Drugs Revenue & Forecasts
        6.2.1 By Region - Global Anemia Treatment Drugs Revenue, 2017-2022
        6.2.2 By Region - Global Anemia Treatment Drugs Revenue, 2023-2028
        6.2.3 By Region - Global Anemia Treatment Drugs Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Anemia Treatment Drugs Revenue, 2017-2028
        6.3.2 US Anemia Treatment Drugs Market Size, 2017-2028
        6.3.3 Canada Anemia Treatment Drugs Market Size, 2017-2028
        6.3.4 Mexico Anemia Treatment Drugs Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Anemia Treatment Drugs Revenue, 2017-2028
        6.4.2 Germany Anemia Treatment Drugs Market Size, 2017-2028
        6.4.3 France Anemia Treatment Drugs Market Size, 2017-2028
        6.4.4 U.K. Anemia Treatment Drugs Market Size, 2017-2028
        6.4.5 Italy Anemia Treatment Drugs Market Size, 2017-2028
        6.4.6 Russia Anemia Treatment Drugs Market Size, 2017-2028
        6.4.7 Nordic Countries Anemia Treatment Drugs Market Size, 2017-2028
        6.4.8 Benelux Anemia Treatment Drugs Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Anemia Treatment Drugs Revenue, 2017-2028
        6.5.2 China Anemia Treatment Drugs Market Size, 2017-2028
        6.5.3 Japan Anemia Treatment Drugs Market Size, 2017-2028
        6.5.4 South Korea Anemia Treatment Drugs Market Size, 2017-2028
        6.5.5 Southeast Asia Anemia Treatment Drugs Market Size, 2017-2028
        6.5.6 India Anemia Treatment Drugs Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Anemia Treatment Drugs Revenue, 2017-2028
        6.6.2 Brazil Anemia Treatment Drugs Market Size, 2017-2028
        6.6.3 Argentina Anemia Treatment Drugs Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Anemia Treatment Drugs Revenue, 2017-2028
        6.7.2 Turkey Anemia Treatment Drugs Market Size, 2017-2028
        6.7.3 Israel Anemia Treatment Drugs Market Size, 2017-2028
        6.7.4 Saudi Arabia Anemia Treatment Drugs Market Size, 2017-2028
        6.7.5 UAE Anemia Treatment Drugs Market Size, 2017-2028
7 Players Profiles
    7.1 Pfizer, Inc.
        7.1.1 Pfizer, Inc. Corporate Summary
        7.1.2 Pfizer, Inc. Business Overview
        7.1.3 Pfizer, Inc. Anemia Treatment Drugs Major Product Offerings
        7.1.4 Pfizer, Inc. Anemia Treatment Drugs Revenue in Global Market (2017-2022)
        7.1.5 Pfizer, Inc. Key News
    7.2 Amgen, Inc.
        7.2.1 Amgen, Inc. Corporate Summary
        7.2.2 Amgen, Inc. Business Overview
        7.2.3 Amgen, Inc. Anemia Treatment Drugs Major Product Offerings
        7.2.4 Amgen, Inc. Anemia Treatment Drugs Revenue in Global Market (2017-2022)
        7.2.5 Amgen, Inc. Key News
    7.3 Hoffmann-La Roche Ltd.
        7.3.1 Hoffmann-La Roche Ltd. Corporate Summary
        7.3.2 Hoffmann-La Roche Ltd. Business Overview
        7.3.3 Hoffmann-La Roche Ltd. Anemia Treatment Drugs Major Product Offerings
        7.3.4 Hoffmann-La Roche Ltd. Anemia Treatment Drugs Revenue in Global Market (2017-2022)
        7.3.5 Hoffmann-La Roche Ltd. Key News
    7.4 Merck Sharp & Dohme Corp.
        7.4.1 Merck Sharp & Dohme Corp. Corporate Summary
        7.4.2 Merck Sharp & Dohme Corp. Business Overview
        7.4.3 Merck Sharp & Dohme Corp. Anemia Treatment Drugs Major Product Offerings
        7.4.4 Merck Sharp & Dohme Corp. Anemia Treatment Drugs Revenue in Global Market (2017-2022)
        7.4.5 Merck Sharp & Dohme Corp. Key News
    7.5 Novartis AG
        7.5.1 Novartis AG Corporate Summary
        7.5.2 Novartis AG Business Overview
        7.5.3 Novartis AG Anemia Treatment Drugs Major Product Offerings
        7.5.4 Novartis AG Anemia Treatment Drugs Revenue in Global Market (2017-2022)
        7.5.5 Novartis AG Key News
    7.6 Janssen Pharmaceutical
        7.6.1 Janssen Pharmaceutical Corporate Summary
        7.6.2 Janssen Pharmaceutical Business Overview
        7.6.3 Janssen Pharmaceutical Anemia Treatment Drugs Major Product Offerings
        7.6.4 Janssen Pharmaceutical Anemia Treatment Drugs Revenue in Global Market (2017-2022)
        7.6.5 Janssen Pharmaceutical Key News
    7.7 Bayer AG
        7.7.1 Bayer AG Corporate Summary
        7.7.2 Bayer AG Business Overview
        7.7.3 Bayer AG Anemia Treatment Drugs Major Product Offerings
        7.7.4 Bayer AG Anemia Treatment Drugs Revenue in Global Market (2017-2022)
        7.7.5 Bayer AG Key News
    7.8 AMAG Pharmaceuticals
        7.8.1 AMAG Pharmaceuticals Corporate Summary
        7.8.2 AMAG Pharmaceuticals Business Overview
        7.8.3 AMAG Pharmaceuticals Anemia Treatment Drugs Major Product Offerings
        7.8.4 AMAG Pharmaceuticals Anemia Treatment Drugs Revenue in Global Market (2017-2022)
        7.8.5 AMAG Pharmaceuticals Key News
    7.9 GlaxoSmithKline plc
        7.9.1 GlaxoSmithKline plc Corporate Summary
        7.9.2 GlaxoSmithKline plc Business Overview
        7.9.3 GlaxoSmithKline plc Anemia Treatment Drugs Major Product Offerings
        7.9.4 GlaxoSmithKline plc Anemia Treatment Drugs Revenue in Global Market (2017-2022)
        7.9.5 GlaxoSmithKline plc Key News
    7.10 Akebia Therapeutics
        7.10.1 Akebia Therapeutics Corporate Summary
        7.10.2 Akebia Therapeutics Business Overview
        7.10.3 Akebia Therapeutics Anemia Treatment Drugs Major Product Offerings
        7.10.4 Akebia Therapeutics Anemia Treatment Drugs Revenue in Global Market (2017-2022)
        7.10.5 Akebia Therapeutics Key News
    7.11 Vifor Pharma Management, Ltd.
        7.11.1 Vifor Pharma Management, Ltd. Corporate Summary
        7.11.2 Vifor Pharma Management, Ltd. Business Overview
        7.11.3 Vifor Pharma Management, Ltd. Anemia Treatment Drugs Major Product Offerings
        7.11.4 Vifor Pharma Management, Ltd. Anemia Treatment Drugs Revenue in Global Market (2017-2022)
        7.11.5 Vifor Pharma Management, Ltd. Key News
    7.12 FibroGen, Inc.
        7.12.1 FibroGen, Inc. Corporate Summary
        7.12.2 FibroGen, Inc. Business Overview
        7.12.3 FibroGen, Inc. Anemia Treatment Drugs Major Product Offerings
        7.12.4 FibroGen, Inc. Anemia Treatment Drugs Revenue in Global Market (2017-2022)
        7.12.5 FibroGen, Inc. Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Anemia Treatment Drugs Market Opportunities & Trends in Global Market
    Table 2. Anemia Treatment Drugs Market Drivers in Global Market
    Table 3. Anemia Treatment Drugs Market Restraints in Global Market
    Table 4. Key Players of Anemia Treatment Drugs in Global Market
    Table 5. Top Anemia Treatment Drugs Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Anemia Treatment Drugs Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Anemia Treatment Drugs Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Anemia Treatment Drugs Product Type
    Table 9. List of Global Tier 1 Anemia Treatment Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Anemia Treatment Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Anemia Treatment Drugs Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Anemia Treatment Drugs Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Anemia Treatment Drugs Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Anemia Treatment Drugs Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Anemia Treatment Drugs Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Anemia Treatment Drugs Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Anemia Treatment Drugs Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Anemia Treatment Drugs Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Anemia Treatment Drugs Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Anemia Treatment Drugs Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Anemia Treatment Drugs Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Anemia Treatment Drugs Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Anemia Treatment Drugs Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Anemia Treatment Drugs Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Anemia Treatment Drugs Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Anemia Treatment Drugs Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Anemia Treatment Drugs Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Anemia Treatment Drugs Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Anemia Treatment Drugs Revenue, (US$, Mn), 2023-2028
    Table 30. Pfizer, Inc. Corporate Summary
    Table 31. Pfizer, Inc. Anemia Treatment Drugs Product Offerings
    Table 32. Pfizer, Inc. Anemia Treatment Drugs Revenue (US$, Mn), (2017-2022)
    Table 33. Amgen, Inc. Corporate Summary
    Table 34. Amgen, Inc. Anemia Treatment Drugs Product Offerings
    Table 35. Amgen, Inc. Anemia Treatment Drugs Revenue (US$, Mn), (2017-2022)
    Table 36. Hoffmann-La Roche Ltd. Corporate Summary
    Table 37. Hoffmann-La Roche Ltd. Anemia Treatment Drugs Product Offerings
    Table 38. Hoffmann-La Roche Ltd. Anemia Treatment Drugs Revenue (US$, Mn), (2017-2022)
    Table 39. Merck Sharp & Dohme Corp. Corporate Summary
    Table 40. Merck Sharp & Dohme Corp. Anemia Treatment Drugs Product Offerings
    Table 41. Merck Sharp & Dohme Corp. Anemia Treatment Drugs Revenue (US$, Mn), (2017-2022)
    Table 42. Novartis AG Corporate Summary
    Table 43. Novartis AG Anemia Treatment Drugs Product Offerings
    Table 44. Novartis AG Anemia Treatment Drugs Revenue (US$, Mn), (2017-2022)
    Table 45. Janssen Pharmaceutical Corporate Summary
    Table 46. Janssen Pharmaceutical Anemia Treatment Drugs Product Offerings
    Table 47. Janssen Pharmaceutical Anemia Treatment Drugs Revenue (US$, Mn), (2017-2022)
    Table 48. Bayer AG Corporate Summary
    Table 49. Bayer AG Anemia Treatment Drugs Product Offerings
    Table 50. Bayer AG Anemia Treatment Drugs Revenue (US$, Mn), (2017-2022)
    Table 51. AMAG Pharmaceuticals Corporate Summary
    Table 52. AMAG Pharmaceuticals Anemia Treatment Drugs Product Offerings
    Table 53. AMAG Pharmaceuticals Anemia Treatment Drugs Revenue (US$, Mn), (2017-2022)
    Table 54. GlaxoSmithKline plc Corporate Summary
    Table 55. GlaxoSmithKline plc Anemia Treatment Drugs Product Offerings
    Table 56. GlaxoSmithKline plc Anemia Treatment Drugs Revenue (US$, Mn), (2017-2022)
    Table 57. Akebia Therapeutics Corporate Summary
    Table 58. Akebia Therapeutics Anemia Treatment Drugs Product Offerings
    Table 59. Akebia Therapeutics Anemia Treatment Drugs Revenue (US$, Mn), (2017-2022)
    Table 60. Vifor Pharma Management, Ltd. Corporate Summary
    Table 61. Vifor Pharma Management, Ltd. Anemia Treatment Drugs Product Offerings
    Table 62. Vifor Pharma Management, Ltd. Anemia Treatment Drugs Revenue (US$, Mn), (2017-2022)
    Table 63. FibroGen, Inc. Corporate Summary
    Table 64. FibroGen, Inc. Anemia Treatment Drugs Product Offerings
    Table 65. FibroGen, Inc. Anemia Treatment Drugs Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Anemia Treatment Drugs Segment by Type in 2021
    Figure 2. Anemia Treatment Drugs Segment by Application in 2021
    Figure 3. Global Anemia Treatment Drugs Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Anemia Treatment Drugs Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Anemia Treatment Drugs Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Anemia Treatment Drugs Revenue in 2021
    Figure 8. By Type - Global Anemia Treatment Drugs Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Anemia Treatment Drugs Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Anemia Treatment Drugs Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Anemia Treatment Drugs Revenue Market Share, 2017-2028
    Figure 12. US Anemia Treatment Drugs Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Anemia Treatment Drugs Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Anemia Treatment Drugs Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Anemia Treatment Drugs Revenue Market Share, 2017-2028
    Figure 16. Germany Anemia Treatment Drugs Revenue, (US$, Mn), 2017-2028
    Figure 17. France Anemia Treatment Drugs Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Anemia Treatment Drugs Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Anemia Treatment Drugs Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Anemia Treatment Drugs Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Anemia Treatment Drugs Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Anemia Treatment Drugs Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Anemia Treatment Drugs Revenue Market Share, 2017-2028
    Figure 24. China Anemia Treatment Drugs Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Anemia Treatment Drugs Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Anemia Treatment Drugs Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Anemia Treatment Drugs Revenue, (US$, Mn), 2017-2028
    Figure 28. India Anemia Treatment Drugs Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Anemia Treatment Drugs Revenue Market Share, 2017-2028
    Figure 30. Brazil Anemia Treatment Drugs Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Anemia Treatment Drugs Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Anemia Treatment Drugs Revenue Market Share, 2017-2028
    Figure 33. Turkey Anemia Treatment Drugs Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Anemia Treatment Drugs Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Anemia Treatment Drugs Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Anemia Treatment Drugs Revenue, (US$, Mn), 2017-2028
    Figure 37. Pfizer, Inc. Anemia Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Amgen, Inc. Anemia Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Hoffmann-La Roche Ltd. Anemia Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Merck Sharp & Dohme Corp. Anemia Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Novartis AG Anemia Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Janssen Pharmaceutical Anemia Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Bayer AG Anemia Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. AMAG Pharmaceuticals Anemia Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. GlaxoSmithKline plc Anemia Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Akebia Therapeutics Anemia Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 47. Vifor Pharma Management, Ltd. Anemia Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 48. FibroGen, Inc. Anemia Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
61
Frequently Asked Questions
Anemia Treatment Drugs Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Anemia Treatment Drugs Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Anemia Treatment Drugs Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Mobile Food Vehicles Market

Mobile food vehicle is the business of selling prepared food from some sort of vehicle. Read More